undamentalytics Newsletter
Sign in

Senseonics Holdings, Inc. (SENS) stock

Add to watchlist

Add holding +

NASDAQ: SENS Nasdaq Health Care Equipment Next results ~November 9, 2026

C Fundamentals grade

Senseonics Holdings, Inc. is a US-listed company in the health care equipment industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Model estimate per share

~$2.3

Forward price-to-sales vs peers

Base case. Range ~$2.3–$8.7. Next year's consensus sales per share times peers' typical forward price-to-sales; only when earnings are negative.

Price vs value

No Buy/Hold/Sell rating is issued: valued with our growth model, which doesn't carry a Buy/Hold/Sell rating yet.

Senseonics Holdings, Inc. valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders4 buying, 0 selling8 purchases and 0 sales by directors and officers, last 12 monthsInsider trades
  • Funds71 adding, 32 cuttingOf 22 active managers that changed their stake, 13 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Senseonics Holdings files

Where Senseonics stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $49m, up 90.6% on a year earlier, faster than the 71.9% growth a quarter earlier. That growth ranks 4 of 103 among the health care equipment companies we cover. Free-cash-flow margin rose to -199.5% from -215.2% a year earlier. Operating margin widened to -223.2% from -255.0%. Against its peers on growth, profitability, cash generation and balance sheet, it grades D. It passes 2 of our 6 financial-health checks.

Source: 10-Q filed August 6, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~November 9, 2026 (estimated)

Senseonics Holdings, Inc.'s trailing-twelve-month revenue grew 90.6% year on year, with a free-cash-flow margin of -199.5%. Where it stands out: revenue growth of 90.6% ranks 5 of 129 health care equipment companies we cover. Where it lags: free-cash-flow margin of -199.5% ranks 110 of 128 health care equipment companies we cover.

Current signal Revenue growth accelerating: TTM revenue growth rose to 90.6% (+18.7pp vs the prior quarter).

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Fast growth. Revenue grew 90.6% over the last 12 months, against a median of 9.1% for health care equipment companies we cover.
  • Growth speeding up. The growth rate is 18.7 points higher than a quarter earlier.
  • Margins widening. Operating margin is up 31.7 points on a year ago.
  • Shrinking share count. Diluted shares fell 2.8% in a year, so each share owns more of the business.

Things to watch

  • Loss-making. Operating margin is -223.2%: costs exceed revenue.
  • Burning cash. Free cash flow was -199.5% of revenue over the last 12 months.
  • Heavy stock-based pay. Stock pay equals 23.2% of revenue, against a median of 6.1% for health care equipment companies we cover: a real cost that cash-flow figures leave out.
  • Volatile shares. Over the past year the shares showed annualised volatility of 80% and a beta of 2.3 against the S&P 500.
  • Below peers: days sales outstanding. Days sales outstanding of 77 days ranks 93 of 118 health care equipment companies we cover (median 57 days).
  • Missing expectations. Earnings per share fell short of the consensus estimate in 4 of the last four quarters.

Latest results: FY2026 Q2

Filed August 6, 2026
Earnings per share
-$0.63 against an average estimate of -$0.62: missed by 1.3%
Revenue
$14m, up 117.8% on a year earlier
Share reaction
+35.5% in the first session after the results on August 6, 2026, against +0.5% for the S&P 500
Next report
November 9, 2026; average EPS estimate -$0.52

Senseonics Holdings' figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day-1.8%
  • 1 week+5.9%
  • 1 month-10.7%
  • This year+62.7%
  • 1 year+28.2%
  • 5 years-88.7%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$48.5M
Operating margin
-223.2%
Net margin
-225.3%
EPS (TTM, diluted)
$-2.26

Growth

Revenue growth
+90.6%
Change in growth rate
+18.7 pts

Cash

Free cash flow (TTM)
-$96.8M
FCF margin
-199.5%
Stock pay % of revenue
23.2%

Earnings

Last results
August 6, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Results

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Senseonics Holdings, Inc. valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: valued with our growth model, which doesn't carry a Buy/Hold/Sell rating yet.

Valuation models

We value Senseonics Holdings, Inc. as an operating company, with every model that fits that kind of business. Cost of equity 10.9%: the 10-year Treasury yield (4.9%) plus a beta of 1.32 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Growth cash-flow model Revenue for this year and next from analysts' consensus, then growth fading to 2.5%; the operating margin moving to profitable peers'; investment needed per dollar of growth from peers; reduced by a failure probability. For young or fast-growing companies. The starting margin is normalized to between -100% and 60%; net margin is a proxy when operating income is not tagged. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$0.7 Left out: out of range vs price (0.08x)
Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. — Does not apply: no positive earnings in the latest twelve months
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. — Does not apply: return on equity above 40%: buybacks or intangibles make book value too small an anchor
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. — Does not apply: return on equity is not positive
Forward price-to-sales vs peers Next year's consensus sales per share times peers' typical forward price-to-sales; only when earnings are negative. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$2.3 ~$2.5–$8.7 Included, half weight
Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable. — Does not apply: revenue and margins don't support a positive value
Combined value Weighted average of the models that apply: the primary model (growth cash-flow model) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$2.3 ~$2.3–$8.7 1 model

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Senseonics Holdings, Inc. with Health Care Equipment in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Valuation multiples over time Market data may be delayed

At fiscal year end 20152016201720182019202020212022202320242025Now
Share price$65.00$53.40$53.20$51.80$18.32$17.44$53.40$20.60$11.40$10.46$5.52$8.98
Market value$23m$238m$308m$408m$173m$199m$1.1bn$637m$324m$329m$230m$435m
+ Net debt (− = net cash)$6m$6m$8m−$69m$47m$97m$71m$66m−$29m−$17m−$544000$16m
Enterprise value$29m$244m$317m$339m$220m$296m$1.2bn$703m$295m$313m$230m$452m
Multiples
Price / sales n/mn/m48.4x21.6x8.1x40.2x82.5x38.9x14.5x14.7x6.5x9.0x
Price / earnings ———————4.5x————
Price / free cash flow ————————————
EV / EBITDA ————————————

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

10 /100

Weak moat

How hard Senseonics Holdings's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 0 / 20

    Net income has been a median -67.0% of total assets over 10 years.

  • Pricing power 0 / 20

    Gross margin has been a median 4.6%, moving by 81.2 percentage points (standard deviation) across 10 years.

  • Durability 10 / 20

    Operating margin has been a median -458.0%; its worst year was -2618.6%.

  • Cash conversion 0 / 20

    Free cash flow was positive in 0 of 10 years, at a median -461.3% of revenue.

  • Discipline 0 / 20

    The diluted share count rose 370.2% over five years; stock-based pay has been a median 42.9% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: November 9, 2026, after the close. Analysts expect revenue of $16m and EPS of −$0.52 (range −$0.64 to −$0.41) for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current −$2.29 −38% $64m +82%
Next −$1.95 +15% $100m +56%

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is −6.7% on 90 days ago. In the last 30 days, 1 analyst raised Senseonics Holdings, Inc.'s forecast and 0 cut it.

Consensus EPS forecast Senseonics Holdings, Inc., last 90 days
−$3.00 −$2.00 −$1.00 $0.00 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: −$2.45 Current fiscal year, 60 days ago: −$2.29 Current fiscal year, 30 days ago: −$2.29 Current fiscal year, 7 days ago: −$2.29 Current fiscal year, Now: −$2.29 −$2.29 Next fiscal year, 90 days ago: −$2.19 Next fiscal year, 60 days ago: −$1.95 Next fiscal year, 30 days ago: −$1.95 Next fiscal year, 7 days ago: −$1.95 Next fiscal year, Now: −$1.95 −$1.95

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago −$2.45−$2.19
60 days ago −$2.29−$1.95
30 days ago −$2.29−$1.95
7 days ago −$2.29−$1.95
Now −$2.29−$1.95

Earnings against estimates

Quarter toEstimateActualSurprise
Jun 2026 −$0.62 −$0.63 −1.3%
Mar 2026 −$0.70 −$0.71 −1.1%
Dec 2025 −$0.43 −$0.46 −6.1%
Sept 2025 −$0.40 −$0.43 −6.7%

Adjusted EPS as companies report it, against the average analyst estimate.

Analyst recommendations

8 analysts, Oct 2026
Buy450%
Hold338%
Sell113%

Monthly trend

  1. Oct 20264318
  2. Sep 20264217
  3. Aug 20264217
  4. Jul 20264217

Counts of recommendations published by analysts covering Senseonics Holdings, Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
9.5%
of tradable shares
Days to cover
6.68
at average volume
Short interest, 1 month
−4%
to October 15, 2026
Held by institutions
40%
of shares
Held by insiders
9.9%
of shares
Employees
130
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

Recent prices are available. Older price history and the statistics that need it are being loaded in the background.

What moved the share price

Last 12 months +27.4%

$7.05 on October 31, 2025 to $8.98

ThenNowEffect
Revenue (last 12 months) $25m $49m +90.6%
P/S multiple 9.6x 9.0x −6.4%
Share count 35m 48m −28.6%

Biggest factor: revenue. Loss-making at one end, so the split uses price/sales.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
SENS+206%−61%−45%−8%−47%+63%
Industry peers (median)−9%−37%−8%−20%−16%−15%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
SENS42%33%50%25%25%46%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
SENS−68%−75%−61%−65%−80%−42%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since December 22, 2015: 95% from February 16, 2021 to July 22, 2026. Getting back needed a 2069% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$4.86 – $10.34
From 52-week high
−13.2%
vs 50-day average
−2.1%
vs 200-day average
+24.5%
Volatility (1 year)
80%
Beta vs S&P 500
2.29

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
2 up, 10 down
typical move ±11.6%
After a week
3 up, 9 down
typical move ±17.1%
After a month
5 up, 7 down
typical move ±24.7%
Results releasedNext dayS&P 500 next day5 days21 days
August 6, 2026 +35.5% +0.5% +49.2% +85.9%
May 7, 2026 −6.2% +0.5% +8.6% +33.0%
May 1, 2026 −24.2% −0.1% −23.9% +3.9%
March 2, 2026 −17.5% −0.8% −23.7% −19.5%
January 12, 2026 −1.2% 0.0% −1.7% +6.6%
November 5, 2025 −7.0% −0.7% −1.5% −1.0%
October 6, 2025 +1.3% 0.0% −9.5% −27.8%
August 6, 2025 −8.5% +0.7% −4.7% −9.5%
May 8, 2025 −9.4% +0.6% −20.3% −23.2%
March 3, 2025 −17.4% −2.9% −31.3% −21.8%
January 13, 2025 −4.1% +0.3% +16.5% +50.6%
November 7, 2024 −7.2% +1.2% −14.7% −13.2%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Senseonics Holdings, Inc. in five measures

Fundamentals grade C
Growth Profitability Cash Balance sheet

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Senseonics Holdings, Inc.
$10M $20M $30M $40M $50M FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue (TTM), FY23 Q3: $19.9M Revenue (TTM), FY23 Q4: $22.4M Revenue (TTM), FY24 Q1: $23.3M Revenue (TTM), FY24 Q2: $24M Revenue (TTM), FY24 Q3: $22.2M Revenue (TTM), FY24 Q4: $22.5M Revenue (TTM), FY25 Q1: $23.7M Revenue (TTM), FY25 Q2: $25.5M Revenue (TTM), FY25 Q3: $29.3M Revenue (TTM), FY25 Q4: $35.3M Revenue (TTM), FY26 Q1: $40.7M Revenue (TTM), FY26 Q2: $48.5M $48.5M

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue (TTM)
FY23 Q3 $19.9M
FY23 Q4 $22.4M
FY24 Q1 $23.3M
FY24 Q2 $24M
FY24 Q3 $22.2M
FY24 Q4 $22.5M
FY25 Q1 $23.7M
FY25 Q2 $25.5M
FY25 Q3 $29.3M
FY25 Q4 $35.3M
FY26 Q1 $40.7M
FY26 Q2 $48.5M
Revenue growth, TTM YoY Senseonics Holdings, Inc.
0% 50% 100% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue growth, TTM YoY, FY23 Q3: 34.4% Revenue growth, TTM YoY, FY23 Q4: 36.6% Revenue growth, TTM YoY, FY24 Q1: 29.1% Revenue growth, TTM YoY, FY24 Q2: 30.3% Revenue growth, TTM YoY, FY24 Q3: 11.4% Revenue growth, TTM YoY, FY24 Q4: 0.4% Revenue growth, TTM YoY, FY25 Q1: 1.6% Revenue growth, TTM YoY, FY25 Q2: 5.9% Revenue growth, TTM YoY, FY25 Q3: 31.9% Revenue growth, TTM YoY, FY25 Q4: 56.9% Revenue growth, TTM YoY, FY26 Q1: 71.9% Revenue growth, TTM YoY, FY26 Q2: 90.6% 90.6%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q3 34.4%
FY23 Q4 36.6%
FY24 Q1 29.1%
FY24 Q2 30.3%
FY24 Q3 11.4%
FY24 Q4 0.4%
FY25 Q1 1.6%
FY25 Q2 5.9%
FY25 Q3 31.9%
FY25 Q4 56.9%
FY26 Q1 71.9%
FY26 Q2 90.6%
Operating margin (TTM) Senseonics Holdings, Inc.
-400% -300% -200% -100% 0% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Operating margin (TTM), FY23 Q3: -388.6% Operating margin (TTM), FY23 Q4: -337.7% Operating margin (TTM), FY24 Q1: -318.1% Operating margin (TTM), FY24 Q2: -306.8% Operating margin (TTM), FY24 Q3: -349.4% Operating margin (TTM), FY24 Q4: -333.1% Operating margin (TTM), FY25 Q1: -296.0% Operating margin (TTM), FY25 Q2: -255.0% Operating margin (TTM), FY25 Q3: -210.5% Operating margin (TTM), FY25 Q4: -193.8% Operating margin (TTM), FY26 Q1: -213.0% Operating margin (TTM), FY26 Q2: -223.2% -223.2%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q3 -388.6%
FY23 Q4 -337.7%
FY24 Q1 -318.1%
FY24 Q2 -306.8%
FY24 Q3 -349.4%
FY24 Q4 -333.1%
FY25 Q1 -296.0%
FY25 Q2 -255.0%
FY25 Q3 -210.5%
FY25 Q4 -193.8%
FY26 Q1 -213.0%
FY26 Q2 -223.2%
FCF margin (TTM) Senseonics Holdings, Inc.
-400% -300% -200% -100% 0% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 FCF margin (TTM), FY23 Q3: -364.9% FCF margin (TTM), FY23 Q4: -314.9% FCF margin (TTM), FY24 Q1: -305.5% FCF margin (TTM), FY24 Q2: -276.4% FCF margin (TTM), FY24 Q3: -286.7% FCF margin (TTM), FY24 Q4: -279.0% FCF margin (TTM), FY25 Q1: -247.6% FCF margin (TTM), FY25 Q2: -215.2% FCF margin (TTM), FY25 Q3: -191.7% FCF margin (TTM), FY25 Q4: -170.9% FCF margin (TTM), FY26 Q1: -186.4% FCF margin (TTM), FY26 Q2: -199.5% -199.5%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q3 -364.9%
FY23 Q4 -314.9%
FY24 Q1 -305.5%
FY24 Q2 -276.4%
FY24 Q3 -286.7%
FY24 Q4 -279.0%
FY25 Q1 -247.6%
FY25 Q2 -215.2%
FY25 Q3 -191.7%
FY25 Q4 -170.9%
FY26 Q1 -186.4%
FY26 Q2 -199.5%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2015 Dec 2015 2016 Dec 2016 2017 Dec 2017 2018 Dec 2018 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Jun 2026
Income
Revenue 0 0 6 19 21 5 14 16 22 22 35 49
Gross profit 0 −0 −3 −8 −19 −17 −1 3 3 1 16 27
EBITDA −29 −42 −56 −87 −130 −78 −56 −68 −74 −73 −67 −107
Operating income −29 −42 −56 −88 −131 −79 −57 −69 −76 −75 −68 −108
Net income −30 −44 −59 −94 −116 −175 −302 142 −60 −79 −69 −109
Diluted EPS −$86.40 −$0.49 −$0.51 −$0.60 −$0.61 −$0.77 −$0.72 −$0.11 −$0.11 −$2.50 −$1.66 −$2.26
Growth (year on year)
Revenue — +773.7% +>999% +196.8% +12.6% −76.8% +176.3% +19.8% +36.6% +0.4% +56.9% +90.6%
Net income — — — — — — — — −142.5% — — —
Margins
Gross margin 100.0% −98.8% −53.1% −43.1% −91.3% −351.6% −5.9% 16.6% 13.8% 2.4% 44.7% 54.9%
EBITDA margin <−999% <−999% −880.1% −461.6% −608.7% <−999% −409.1% −412.7% −332.0% −326.5% −189.5% −219.4%
Operating margin <−999% <−999% −883.6% −463.1% −613.4% <−999% −418.1% −418.7% −337.7% −333.0% −193.8% −223.2%
Net margin <−999% <−999% −927.4% −497.0% −542.2% <−999% <−999% 867.0% −269.8% −349.8% −196.0% −225.3%
Free-cash-flow margin <−999% <−999% −880.0% −485.2% −643.6% <−999% −411.6% −406.5% −314.9% −279.0% −170.9% −199.5%
Cash flow
Cash from operations −25 −38 −56 −91 −136 −67 −56 −66 −70 −60 −59 −96
Capital spending 0 0 0 1 1 0 0 0 0 2 1 1
Free cash flow −26 −38 −56 −92 −137 −68 −56 −67 −71 −63 −60 −97
Stock-based pay 1 2 4 6 8 7 9 9 9 9 10 11
Free cash flow after stock pay −27 −41 −60 −98 −145 −75 −65 −75 −79 −72 −70 −108
Balance sheet
Cash 4 13 16 137 96 18 33 36 76 75 40 45
Total debt 10 19 24 68 143 115 105 102 47 58 40 61
Net debt (negative = net cash) 6 6 8 −69 47 97 71 66 −29 −17 −1 16
Diluted shares — 4m 6m 8m 9m 11m 21m 31m 28m 31m 42m 48m

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

2 of 6 checks passed · June 30, 2026
What it owns · $177m
Short-term assets $166mLonger-term assets $10m
What it owes, and who funded it · $177m
Short-term liabilities $25mLonger-term liabilities $62mShareholders' equity $90m
  • Short-term assets cover short-term liabilities $166m of assets due within a year against $25m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $166m short-term assets against $62m of longer-dated liabilities.
  • More cash than debt $45m of cash against $56m of debt.
  • Debt below 40% of shareholders' equity Debt is 62% of equity.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt −$96m of operating cash flow against $56m of debt.
  • Operating profit covers interest at least five times over Operating income of −$108m against $5m of interest.

From Senseonics Holdings, Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

R&D spending
75.9%
of revenue
Sales & admin spending
202.2%
of revenue
Days sales outstanding
77 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in health care equipment
Last 12 months unless stated SENS IRIX CLPT KRMD TLSI SNWV Median
Revenue, last 12 months $49m $52m $45m $45m $45m $44m $99m
Revenue growth, last 12 months 90.6% 3.7% 32.5% 22.4% 25.2% 12.7% 9.2%
Revenue growth, 3-year average 38.0% −2.9% 26.8% 15.3% 45.1% 34.4% 13.5%
Revenue growth, latest quarter 117.8% −7.4% 36.3% 18.2% 1.7% −3.1% 10.2%
Gross margin 54.9% 35.9% 61.4% 62.4% 85.8% 76.3% 61.2%
Operating margin −223.2% −5.4% −70.6% −3.7% −67.7% 3.4% −8.5%
Operating margin, 3-year average −261.7% −11.3% −66.2% −13.3% −122.3% 7.0% −17.9%
Net margin −225.3% −6.9% −79.4% −4.0% −62.6% 34.7% −12.0%
Cash from operations / revenue −197.6% −3.4% −103.6% 3.1% −50.6% 11.9% −1.9%
Free-cash-flow margin −199.5% −3.9% −105.9% 1.6% −51.6% 9.6% −3.9%
Free-cash-flow margin, 3-year average −230.3% −9.1% −58.5% −2.7% −119.5% −0.8% −7.0%
Stock pay / revenue 23.2% 1.4% 18.4% 6.1% 23.6% 13.4% 6.1%
Change in share count −2.8% 3.3% 6.7% 2.5% 73.8% 78.4% 4.0%

Median of all 134 companies we cover in health care equipment. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

134 health care equipment companies
Measure Company Peer median Rank
Revenue growth Growth 90.6% 9.1% 5 of 129
Change in growth rate Growth +18.7pp -0.6pp 10 of 129
Gross margin Profitability 54.9% 61.9% 81 of 123
Operating margin Profitability -223.2% -8.3% 111 of 132
Net margin Profitability -225.3% -12.0% 111 of 133
Free-cash-flow margin Cash generation -199.5% -3.4% 110 of 128
Stock pay as % of revenue Cash generation 23.2% 6.1% 101 of 123
Long-term debt as % of assets Balance sheet 31.6% 24.2% 58 of 87
Days sales outstanding Balance sheet 77 days 57 days 93 of 118

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to December 31, 2025
Geography
Region Revenue Share YoY
United States $27.9M 79.2% ▲ 82.7%
Outside the US $7.3M 20.8% ▲ 2.1%

From Senseonics Holdings, Inc.'s 10-K filed March 2, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$118M
Institutions reporting
108
Shares held vs prior quarter
▲ 138.0%
Positions opened / closed
39 / 17

Top buyers and sellers, Q2 2026: 71 institutions bought and 32 sold ; the biggest buyer was Sessa Capital Im, L.P (+2.7M shares) and the biggest seller Millennium Management LLC (−481K). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Sessa Capital Im, L.P. $25.2M 4.4M 21.3% ▲ 151.3%
Blackrock, Inc. $15.9M 2.8M 13.4% ▲ 391.2%
Vanguard Capital Management LLC $10.1M 1.8M 8.5% ▲ 10.0%
Avidity Partners Management LP $9.1M 1.6M 7.7% New
Sio Capital Management, LLC $9M 1.6M 7.6% ▲ 1275.6%
UBS Group AG $8.4M 1.5M 7.1% ▲ 231.8%
Geode Capital Management, LLC $6.4M 1.1M 5.4% ▲ 142.7%
Masters Capital Management LLC $4M 700K 3.4% ▲ 40.0%
State Street Corp $2.9M 511K 2.5% ▲ 183.5%
Marshall Wace, LLP $2.3M 406K 1.9% ▼ 12.6%
Bank Of America Corp $2.2M 394K 1.9% ▲ 592.5%
Charles Schwab Investment Management Inc $2.2M 393K 1.9% ▲ 77.8%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Senseonics Holdings, Inc.'s complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $737,255 8 trades by 4 insiders, last 12 months Insider sales History → $0 0 trades by 0 insiders
Net ▲ $737,255 net buying
Insider Date Trade Shares Price Value
Roeder Douglas A Director August 19, 2026 Buy 13,953 $8.98 $125,300
Roeder Douglas A Director May 12, 2026 Buy 22,686 $5.56 $126,134
Goodnow Timothy T President and CEO March 13, 2026 Buy 17,225 $5.79 $99,733
Roeder Douglas A Director March 13, 2026 Buy 17,500 $5.73 $100,275
Steven Edelman Director November 10, 2025 Buy 10,000 $6.55 $65,500
Goodnow Timothy T President and CEO November 7, 2025 Buy 17,210 $5.87 $101,023
Sullivan Frederick T. Chief Financial Officer November 7, 2025 Buy 5,415 $5.88 $31,840
Roeder Douglas A Director November 7, 2025 Buy 15,000 $5.83 $87,450

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

  • August 6, 2026
  • May 7, 2026
  • May 1, 2026
  • March 2, 2026
  • January 12, 2026
  • November 5, 2025

Recent SEC filings

Data status

When each part of this page on Senseonics Holdings, Inc. was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Senseonics Holdings, Inc. in brief

What does Senseonics Holdings, Inc. do?
Senseonics Holdings, Inc. is a US-listed company in the health care equipment industry. Its financial year ends in December.
What is Senseonics Holdings, Inc.'s stock ticker?
Senseonics Holdings, Inc. trades under the ticker SENS on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Senseonics Holdings, Inc.'s revenue, and how fast is it growing?
Over its most recent trailing twelve months, Senseonics Holdings, Inc. reported revenue of $48.5M, 90.6% higher than a year earlier, according to its SEC filings.
What is Senseonics Holdings, Inc.'s free cash flow?
Senseonics Holdings, Inc.'s free-cash-flow margin is -199.5% of revenue over the trailing twelve months, ranking 110 of the 128 health care equipment companies we cover.
Who are Senseonics Holdings, Inc.'s largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Sessa Capital Im, L.P., Blackrock, Inc. and Vanguard Capital Management LLC. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is Senseonics Holdings, Inc.'s market cap?
On November 2, 2026, Senseonics Holdings, Inc.'s market capitalisation was about $435M and net debt of $16.2M. Market figures come from third-party market data and may be delayed.
How much debt does Senseonics Holdings, Inc. have?
Senseonics Holdings, Inc.'s debt-to-equity ratio is 61.8%, from its latest balance sheet. The financial health section below sets out its other solvency checks.
Who are Senseonics Holdings, Inc.'s competitors?
In our Health Care Equipment peer group, the companies closest to Senseonics Holdings, Inc. are Iridex Corp, Clearpoint Neuro, Inc., Koru Medical Systems, Inc., Trisalus Life Sciences, Inc. and Sanuwave Health, Inc. The side-by-side comparison below sets their revenue, margins and growth against Senseonics Holdings, Inc.'s.
Are insiders buying or selling Senseonics Holdings, Inc. stock?
Over the last 12 months, Senseonics Holdings, Inc.'s directors and officers reported 8 open-market purchases and 0 sales on Form 4. The insider trading page charts every trade.
When is Senseonics Holdings, Inc.'s next earnings date?
Around November 9, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Senseonics Holdings, Inc. announces its own schedule.